Sponsor or institution

Clinical trials and research at Shandong Public Health Clinical Center

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Afatinib plus chemotherapy to convert unresectable EGFR‑mutant stage III NSCLC into resectable disease.

  This trial will see if afatinib combined with chemotherapy can shrink unresectable, EGFR‑sensitive mutation positive stage III non‑small cell lung cancer enough to allow surgery.

  Recruiting Phase 2 Shandong Public Health Clinical Center · Jinan, Shangdong · NCT06709859

• Combining Tislelizumab, Endostatin, and Chemotherapy for Advanced Lung Cancer

  This study is testing a new combination of treatments, including Tislelizumab and chemotherapy, to see if it can help people with advanced lung cancer who can't have surgery feel better and possibly become eligible for surgery.

  Recruiting Phase 2 Shandong Public Health Clinical Center · Jinan, Shandong · NCT06617936

Quick answers

How many clinical trials run by Shandong Public Health Clinical Center are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →